Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator

被引:219
作者
Linfante, I
Llinas, RH
Selim, M
Chaves, C
Kumar, S
Parker, RA
Caplan, LR
Schlaug, G
机构
[1] Beth Israel Deaconess Med Ctr, Div Cerebrovasc Dis, Dept Neurol, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Biomet Ctr, Boston, MA 02115 USA
关键词
carotid artery; internal; computed tomography; magnetic resonance imaging; middle cerebral artery; stroke; thrombolysis; tissue plasminogen activator;
D O I
10.1161/01.STR.0000021001.18101.A5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Early reperfusion is a predictor of good outcome in acute ischemic stroke. We investigated whether middle cerebral artery (MCA) occlusions have a better clinical outcome and proportion of recanalization compared with internal carotid artery (ICA) occlusion after standard treatment with intravenous (IV) tissue plasminogen activator (tPA). Patients-In a retrospective analysis of our prospective stroke database between January 7, 1998, and January 30, 2002, we identified 36 consecutive patients who were treated with IV tPA within 3 hours after symptom onset of a stroke in the distribution of a documented ICA or MCA occlusion. The National Institutes of Health Stroke Scale (NIHSS) score was recorded before tPA, at 24 hours, 3 days, and 3 months after stroke. Three-month outcome was recorded by modified Rankin scale. Magnetic resonance angiography or computed tomographic angiography was obtained before tPA. The presence of recanalization was assessed by transcranial Doppler and/or magnetic resonance angiography within 3 days after stroke onset. Results-Nineteen patients had MCA occlusion, and 17 had ICA-plus-MCA occlusion before tPA. Although there was no difference in age and NIHSS at day 0 between the 2 groups, the MCA group had a lower day 3 NIHSS score compared with the ICA group (P=0.006) in an ANCOVA. In addition, patients who had a MCA occlusion had lower day 1 and 3 NIHSS scores compared with the ICA group (P=0.04 and P=0.03, respectively; Wilcoxon rank sum). Similarly, NIHSS was significantly lower in patients who recanalized on days 1 and 3 (P=0.004 and P=0.003 respectively, Wilcoxon rank sum). When we adjusted for NIHSS score at day 0 in an ANCOVA, the adjusted mean was lower in the group that recanalized compared with the group that did not recanalize (P<0.001). There was a significant difference between the proportion of recanalization in the MCA group (15 of 17 recanalized, 88%) at 3 days after tPA compared with that of the ICA group (5 of 16 recanalized, 31%; P=0.001, Fisher exact test). The 3-month modified Rankin scale was not different between the 2 groups. Conclusions-Despite comparable age and NIHSS scores before IV tPA, MCA occlusions have lower day 1 and 3 NIHSS scores and higher proportion of recanalization compared with ICA occlusions. A combined IV/intra-arterial or mechanical thrombolysis may be needed to achieve early recanalization in ICA occlusions.
引用
收藏
页码:2066 / 2071
页数:6
相关论文
共 40 条
[21]  
Hunter GJ, 1998, AM J NEURORADIOL, V19, P29
[22]  
JANSEN O, 1995, AM J NEURORADIOL, V16, P1977
[23]   Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI [J].
Jansen, O ;
Schellinger, P ;
Fiebach, J ;
Hacke, W ;
Sartor, K .
LANCET, 1999, 353 (9169) :2036-2037
[24]  
Kasner SE, 2000, STROKE, V31, P295
[25]   Evaluation of early reperfusion and IV tPA therapy using diffusion- and perfusion-weighted MRI [J].
Marks, MP ;
Tong, DC ;
Beaulieu, C ;
Albers, GW ;
de Crespigny, A ;
Moseley, ME .
NEUROLOGY, 1999, 52 (09) :1792-1798
[26]   TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].
MARLER, JR ;
BROTT, T ;
BRODERICK, J ;
KOTHARI, R ;
ODONOGHUE, M ;
BARSAN, W ;
TOMSICK, T ;
SPILKER, J ;
MILLER, R ;
SAUERBECK, L ;
JARRELL, J ;
KELLY, J ;
PERKINS, T ;
MCDONALD, T ;
RORICK, M ;
HICKEY, C ;
ARMITAGE, J ;
PERRY, C ;
THALINGER, K ;
RHUDE, R ;
SCHILL, J ;
BECKER, PS ;
HEATH, RS ;
ADAMS, D ;
REED, R ;
KLEI, M ;
HUGHES, S ;
ANTHONY, J ;
BAUDENDISTEL, D ;
ZADICOFF, C ;
RYMER, M ;
BETTINGER, I ;
LAUBINGER, P ;
SCHMERLER, M ;
MEIROSE, G ;
LYDEN, P ;
RAPP, K ;
BABCOCK, T ;
DAUM, P ;
PERSONA, D ;
BRODY, M ;
JACKSON, C ;
LEWIS, S ;
LISS, J ;
MAHDAVI, Z ;
ROTHROCK, J ;
TOM, T ;
ZWEIFLER, R ;
DUNFORD, J ;
ZIVIN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587
[27]   Early stroke treatment associated with better outcome - The NINDS rt-PA Stroke Study [J].
Marler, JR ;
Tilley, BC ;
Lu, M ;
Brott, TG ;
Lyden, PC ;
Grotta, JC ;
Broderick, JP ;
Levine, SR ;
Frankel, MP ;
Horowitz, SH ;
Haley, EC ;
Lewandowski, CA ;
Kwiatkowski, TP .
NEUROLOGY, 2000, 55 (11) :1649-1655
[28]  
MITWALLI AE, 2002, STROKE, V33, P99
[29]   INTRAVENOUS RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE CAROTID-ARTERY TERRITORY STROKE [J].
MORI, E ;
YONEDA, Y ;
TABUCHI, M ;
YOSHIDA, T ;
OHKAWA, S ;
OHSUMI, Y ;
KITANO, K ;
TSUTSUMI, A ;
YAMADORI, A .
NEUROLOGY, 1992, 42 (05) :976-982
[30]   Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke [J].
Qureshi, AI ;
Ali, Z ;
Suri, MFK ;
Kim, SH ;
Shatla, AA ;
Ringer, AJ ;
Lopes, DK ;
Guterman, LR ;
Hopkins, LN .
NEUROSURGERY, 2001, 49 (01) :41-48